Ming Cai

Synergy effects of Ganoderic acid A and Ganoderma lucidum polysaccharides on enhancing protection against DSS-induced colitis via gut microbiota rebalancing and inflammation suppression

Abstract Inflammatory bowel disease (IBD) is characterized by persistent intestinal inflammation and gut microbiota dysbiosis. The study investigated the protective effects of Ganoderma lucidum polysaccharide (GLP) and ganoderic acid A (GAA) administered individually and in combi...